Synagis Medication Information
By binding to the respiratory syncytial virus (RSV), Synagis® (palivizumab) can help prevent the virus from multiplying. This prescription medication does not prevent RSV infections, but it can prevent the infection from becoming severe enough to cause serious problems in infants and children who are at high risk for this.
Although this medicine may help minimize RSV complications, not everyone can use this medication. Information on Synagis should be discussed with your child's healthcare provider before using it to minimize risks and to help ensure safe treatment. For example, your child may not be able to use this medicine if he or she has a blood clotting or bleeding disorder, an upcoming heart surgery, or certain allergies.
Although most children tolerate this medication well, side effects are possible and can include fever, ear infections, and a runny nose. In most cases, reactions to the drug tend to be mild and easy to treat.
(Click Synagis for more information, including a detailed description of the medicine's effects, a list of potential side effects that may occur with treatment, and dosing tips on when and how this medicine is administered.)